Approved labelOctreotide acetate injection prescribing information for acromegaly, carcinoid tumors, and VIPomas
PopulationAdults covered by the approved octreotide indications
DoseAcromegaly starts at 50 mcg three times daily and has a labeled maintenance range of 100-500 mcg three times daily. Carcinoid tumors use 100-600 mcg/day and VIPomas use 200-300 mcg/day in divided doses during the initial 2 weeks.
RouteSubcutaneous or intravenous injection
FrequencyTwo to four divided doses daily depending on indication
DurationLong-term use within the approved indication with response-based adjustment
PreparationReady-to-use 100 mcg/mL or 500 mcg/mL solution in a single-dose vial; no reconstitution.